Sakar Healthcare shares climbed more than 4% on the National Stock Exchange on Monday, reaching an intraday high of ₹833.90, after the company reported a 120% year-on-year increase in net profit for the first quarter of fiscal 2027.
The stock opened at ₹817.45, up from the previous close of ₹802.20, as investors reacted to the robust earnings print released on July 25.
Sakar Healthcare has been a standout performer in the Indian small-cap space, delivering a 350% return over the past five years.
The results underscore the company's continued momentum in the healthcare distribution sector, with profit growth significantly outpacing broader market expectations.
Sakar Healthcare has been a standout performer in the Indian small-cap space, delivering a 350% return over the past five years.
The latest quarterly figures reinforce the stock's status as a multibagger, attracting renewed buying interest from traders focused on high-growth healthcare plays.
The rally follows a similar pattern seen in other Indian small-cap stocks recently, such as Magnus Steel and Infra, which hit its upper circuit earlier in July after strong Q1FY27 results.